DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company Employee Directory

Biotechnology ResearchCalifornia, United States51-200 Employees

At DICE, we are expecting more out of medicine. We design and develop innovative oral medicines against biologically validated targets in immunology for the treatment of chronic autoimmune and inflammatory diseases. Through combining innovative chemistry with well-validated biology, our goal is to make medicines more accessible and unlock the potential of oral medicines.

Our team is led by an exceptional group of scientists, R&D executives and company builders with demonstrated track records of progressing programs from discovery through regulatory approval and commercialization. Together, we’re building a team that has a passion for innovation and extensive experience in small molecule drug discovery and development.

Find DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company employees' phone numbers or email addresses

DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company Global Highlights

Location
Employees

North America
36

Minus sign iconPlus sign icon
  • United States Of America
    35
  • Canada
    1

Africa
3

Minus sign iconPlus sign icon
  • Egypt
    2
  • Uganda
    1

Europe
3

Minus sign iconPlus sign icon
  • Germany
    1
  • Netherlands
    1
  • France
    1

Asia
2

Minus sign iconPlus sign icon
  • India
    2

DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company's Leadership

  • Stylized image of a person
    J. R.
    President
    Phone icon
  • Stylized image of a person
    B. J.
    Founder Board Chairman
    Phone icon
  • Stylized image of a person
    O. Y.
    Vice President, Finance
    Phone icon
  • Stylized image of a person
    R. E.
    Executive Director, Nonclinical Toxicology
    Phone icon
  • Stylized image of a person
    T. H.
    Senior Director Analytical Development
    Phone icon
  • Stylized image of a person
    L. E.
    Controller
    Phone icon
  • Stylized image of a person
    L. E.
    Controller
    Phone icon
  • Stylized image of a person
    D. W.
    Manager, Document Specialist
    Phone icon

Contact profiles from DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    D. W.
    Senior Document Specialist
    Phone icon
    Oct 17, 2024

Frequently Asked Questions

What is DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company known for?

Minus sign iconPlus sign icon
DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company was founded in 2013 operates in the Biotechnology Research industry; you can contact the main corporate office by phone at . Explore DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company's company overview page for more information.

What is DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company's most common email format?

Minus sign iconPlus sign icon
DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company email formats with LeadIQ.

How many employees does DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company have currently?

Minus sign iconPlus sign icon
DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company has approximately 67 employees as of December 2025. These team members are located across 4 continents, including North AmericaAfricaEurope.

Who are DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company's key employees and leadership?

Minus sign iconPlus sign icon

As of December 2025, DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company's key employees include:

  • President: J. R.
  • Founder Board Chairman: B. J.
  • Vice President, Finance: O. Y.
  • Executive Director, Nonclinical Toxicology: R. E.
  • Senior Director Analytical Development: T. H.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.